Article Details
Retrieved on: 2025-02-07 11:42:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Genentech, a member of Roche (RHHBY), announced that a detailed analysis of its Phase III REGENCY trial of Gazyva in people with active lupus ne.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here